NasdaqGS - Delayed Quote USD

Boundless Bio, Inc. (BOLD)

1.6600
-0.0300
(-1.78%)
At close: May 20 at 4:00:01 PM EDT
1.6600
0.00
(0.00%)
After hours: May 20 at 4:02:05 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
73,725
73,267
54,796
46,469
25,301
Operating Income
-73,725
-73,267
-54,796
-46,469
-25,301
Net Non Operating Interest Income Expense
8,056
7,892
5,282
668
96
Other Income Expense
-22
12
80
-100
-5
Pretax Income
-65,691
-65,363
-49,434
-45,901
-25,210
Net Income Common Stockholders
-65,691
-65,363
-49,434
-45,901
-25,210
Diluted NI Available to Com Stockholders
-65,691
-65,363
-49,434
-45,901
-25,210
Basic EPS
7.71
--
-2.22
-3.28
-1.80
Diluted EPS
7.71
--
-2.22
-3.28
-1.80
Basic Average Shares
22,244.5000
--
22,239.3330
13,990
13,990
Diluted Average Shares
22,244.5000
--
22,239.3330
13,990
13,990
Total Operating Income as Reported
-73,725
-73,267
-54,796
-46,469
-25,301
Total Expenses
73,725
73,267
54,796
46,469
25,301
Net Income from Continuing & Discontinued Operation
-65,691
-65,363
-49,434
-45,901
-25,210
Normalized Income
-65,691
-65,363
-49,434
-45,901
-25,210
Interest Income
8,056
7,892
5,282
668
96
Net Interest Income
8,056
7,892
5,282
668
96
EBIT
-73,725
-73,267
-54,796
-46,469
-25,301
EBITDA
-72,585
-72,181
-53,839
-45,527
-24,619
Reconciled Depreciation
1,140
1,086
957
942
682
Net Income from Continuing Operation Net Minority Interest
-65,691
-65,363
-49,434
-45,901
-25,210
Normalized EBITDA
-72,585
-72,181
-53,839
-45,527
-24,619
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/28/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ARTV Artiva Biotherapeutics, Inc.
2.1600
+6.93%
 
PMVP PMV Pharmaceuticals, Inc.
0.9308
+6.50%
 
ATHA Athira Pharma, Inc.
0.2681
-1.43%
 
ZNTL Zentalis Pharmaceuticals, Inc.
1.2800
+2.40%
 
OKUR OnKure Therapeutics, Inc.
2.3200
+5.45%
 
PLRX Pliant Therapeutics, Inc.
1.3700
+1.48%
 
MBX MBX Biosciences, Inc.
12.36
+1.73%
 
ERAS Erasca, Inc.
1.2800
+4.07%
 
ACRV Acrivon Therapeutics, Inc.
1.2500
+5.93%
 
LVTX LAVA Therapeutics N.V.
1.3200
+5.60%